These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 2188823)

  • 1. Angiotensin-converting enzyme inhibitors in chronic renal failure.
    Opsahl JA; Abraham PA; Keane WF
    Drugs; 1990; 39 Suppl 2():23-32. PubMed ID: 2188823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
    Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
    Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ACE inhibitors and the kidney].
    Hörl WH
    Wien Med Wochenschr; 1996; 146(11):231-4; discussion 234-5. PubMed ID: 8928521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and long-term effects of ACE inhibition on renal haemodynamics in glomerular and interstitial nephropathies.
    Guidi E; Minetti EE; Cozzi MG
    J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):40-5. PubMed ID: 11984747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal effects of angiotensin converting enzyme inhibitors: nondiabetic chronic renal disease.
    Opsahl JA; Abraham PA; Keane WF
    Cardiovasc Drugs Ther; 1990 Feb; 4(1):221-8. PubMed ID: 2285614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ACE inhibition on renal haemodynamics in essential hypertension and hypertension associated with chronic renal failure.
    Sánchez RA; Traballi CA; Marcó EJ; Gilbert BH; Ramírez AJ; Long G
    Drugs; 1991; 41 Suppl 1():25-30. PubMed ID: 1712268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nephroprotection by inhibition of the renin-angiotensin system--wish or reality?].
    Barnas U; Mayer G
    Wien Klin Wochenschr; 1995; 107(1):10-4. PubMed ID: 7871784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephroprotective effect of ACE inhibitors.
    Orth S; Nowicki M; Wiecek A; Ritz E
    Drugs; 1993; 46 Suppl 2():189-95; discussion 195-6. PubMed ID: 7512474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibition in renal disease; contrasting effects on renal function in renal artery stenosis and progressive renal injury.
    Jackson B; Johnston CI
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():107-15. PubMed ID: 2674436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic implications of converting-enzyme inhibitors in renal disease.
    Anderson S; Brenner BM
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):81-7. PubMed ID: 3037894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.
    Anderson S; Rennke HG; Brenner BM
    J Clin Invest; 1986 Jun; 77(6):1993-2000. PubMed ID: 3011863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic benefit of converting-enzyme inhibition in progressive renal disease.
    Anderson S; Brenner BM
    Am J Hypertens; 1988 Oct; 1(4 Pt 2):380S-383S. PubMed ID: 3056448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibition and renal protection. An assessment of implications for therapy.
    Hollenberg NK; Raij L
    Arch Intern Med; 1993 Nov; 153(21):2426-35. PubMed ID: 8215747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibitors and progression of chronic renal failure.
    Tolins JP; Raij L
    Kidney Int Suppl; 1990 Nov; 30():S118-22. PubMed ID: 2259070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive renal insufficiency: the role of angiotensin converting enzyme inhibitors.
    Savage S; Schrier RW
    Adv Intern Med; 1992; 37():85-101. PubMed ID: 1558007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive therapy and the progression of renal disease.
    Anderson S
    J Hypertens Suppl; 1989 Sep; 7(7):S39-42. PubMed ID: 2693656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE inhibitors and the kidney. A risk-benefit assessment.
    Navis G; Faber HJ; de Zeeuw D; de Jong PE
    Drug Saf; 1996 Sep; 15(3):200-11. PubMed ID: 8879974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.